Amit Roy

3.8k total citations
112 papers, 2.8k citations indexed

About

Amit Roy is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Amit Roy has authored 112 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 23 papers in Immunology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Amit Roy's work include Cancer Immunotherapy and Biomarkers (36 papers), CAR-T cell therapy research (24 papers) and Biosimilars and Bioanalytical Methods (14 papers). Amit Roy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (36 papers), CAR-T cell therapy research (24 papers) and Biosimilars and Bioanalytical Methods (14 papers). Amit Roy collaborates with scholars based in United States, Germany and Sweden. Amit Roy's co-authors include Feng Yan, Gaurav Bajaj, Manish Gupta, Panagiotis Georgopoulos, Akintunde Bello, Sachin Agrawal, Paul J. Lioy, Brian Lestini, Eric Masson and Shruti Agrawal and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Amit Roy

106 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Amit Roy 1.2k 552 382 376 284 112 2.8k
Bingshu E. Chen 1.5k 1.3× 323 0.6× 551 1.4× 209 0.6× 707 2.5× 147 4.0k
Anastasia Ivanova 951 0.8× 199 0.4× 645 1.7× 176 0.5× 618 2.2× 193 5.1k
Craig A. Beam 1.3k 1.2× 397 0.7× 774 2.0× 1.1k 3.0× 892 3.1× 108 5.3k
Judy Zhong 1.2k 1.0× 903 1.6× 372 1.0× 176 0.5× 1.2k 4.1× 146 3.8k
Hwai‐I Yang 915 0.8× 359 0.7× 327 0.9× 91 0.2× 1.1k 3.7× 178 10.9k
Nhu D. Le 981 0.8× 187 0.3× 941 2.5× 159 0.4× 485 1.7× 103 4.5k
Ivan Nestorov 409 0.4× 623 1.1× 69 0.2× 423 1.1× 463 1.6× 88 2.5k
Marvin A. Schneiderman 868 0.7× 130 0.2× 681 1.8× 147 0.4× 300 1.1× 84 3.3k
Tongzhang Zheng 1.9k 1.7× 432 0.8× 544 1.4× 174 0.5× 1.2k 4.1× 129 6.2k
Serge Koscielny 1.8k 1.6× 220 0.4× 930 2.4× 736 2.0× 1.8k 6.2× 135 5.7k

Countries citing papers authored by Amit Roy

Since Specialization
Citations

This map shows the geographic impact of Amit Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Roy more than expected).

Fields of papers citing papers by Amit Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Roy. The network helps show where Amit Roy may publish in the future.

Co-authorship network of co-authors of Amit Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Roy. A scholar is included among the top collaborators of Amit Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Roy. Amit Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Amit, et al.. (2025). Scoping review of the role of pharmacometrics in model-informed drug development. Journal of Pharmacokinetics and Pharmacodynamics. 52(6). 56–56.
2.
Zhao, Yue, Sai Praneeth Bathena, Paul Statkevich, et al.. (2024). Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors. Clinical Cancer Research. 30(14). 3050–3058. 7 indexed citations
3.
Zhao, Yue, et al.. (2023). Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations—Going beyond the body‐size effect. CPT Pharmacometrics & Systems Pharmacology. 13(3). 476–493. 3 indexed citations
4.
Sangro, Bruno, Thomas Yau, Masatoshi Kudo, et al.. (2023). Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040). Clinical and Translational Science. 16(8). 1445–1457. 8 indexed citations
5.
Kang, Yoon‐Koo, Martin Reck, Paul Nghiem, et al.. (2022). Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials. Journal for ImmunoTherapy of Cancer. 10(4). e004273–e004273. 10 indexed citations
6.
7.
Dercle, Laurent, Matthew Fronheiser, Lin Lü, et al.. (2020). Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics. Clinical Cancer Research. 26(9). 2151–2162. 128 indexed citations
8.
Messaoudi, Nouredin, Isabelle Cousineau, Franck Vandenbroucke‐Menu, et al.. (2018). CD73 as a novel immune target and biomarker in pancreatic adenocarcinoma. HPB. 20. S23–S23. 2 indexed citations
9.
Yan, Feng, Xiaoning Wang, Gaurav Bajaj, et al.. (2017). Nivolumab Exposure–Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(18). 5394–5405. 82 indexed citations
10.
Passey, Chaitali, Johanna Mora, Robert Dodge, et al.. (2017). An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of Elotuzumab. The AAPS Journal. 19(2). 557–567. 9 indexed citations
11.
Roy, Amit, et al.. (2016). Assessment of antihyperglycemic potential of lyophilized and oven-dried extract of Calocybe indica in experimentally streptozotocin-nicotinamide induced diabetic rats. International Journal of Medical Research & Health Sciences. 5(4). 82–88. 1 indexed citations
12.
Zhao, Xiaochen, Satyendra Suryawanshi, Matthew Hruska, et al.. (2016). Assessment of nivolumab (Nivo) benefit-risk profile from a 240-mg flat dose versus a 3-mg/kg dosing regimen in patients (Pts) with solid tumors. Annals of Oncology. 27. vi376–vi376. 3 indexed citations
13.
Gibiansky, Leonid, Chaitali Passey, Amit Roy, Akintunde Bello, & Manish Gupta. (2016). Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma. Journal of Pharmacokinetics and Pharmacodynamics. 43(3). 243–257. 27 indexed citations
14.
Saha, Suman, et al.. (2015). Liposome: method of preparation, advantages, evaluation and its application. SHILAP Revista de lepidopterología. 19 indexed citations
15.
Sahu, Ram Kumar, et al.. (2014). Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. SpringerPlus. 3(1). 695–695. 33 indexed citations
16.
Yan, Feng, Amit Roy, Eric Masson, et al.. (2013). Exposure–Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma. Clinical Cancer Research. 19(14). 3977–3986. 145 indexed citations
17.
Kumar, Rajesh, et al.. (2009). Evaluation of antidiabetic and hypolipidemic effect of Cucumis sativus fruit in streptozotocin-induced-diabetic rats.. Biomedical & Pharmacology Journal. 2(2). 351–355. 10 indexed citations
18.
Adgate, John L., Dana Boyd Barr, C. Andrew Clayton, et al.. (2001). Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample.. Environmental Health Perspectives. 109(6). 583–590. 160 indexed citations
19.
Roy, Amit & Panagiotis Georgopoulos. (1998). Reconstructing week-long exposures to volatile organic compounds using physiologically based pharmacokinetic models.. PubMed. 8(3). 407–22. 21 indexed citations
20.
Weisel, Clifford P., Runlan Yu, Amit Roy, & Panagiotis Georgopoulos. (1996). Biomarkers of environmental benzene exposure.. Environmental Health Perspectives. 104(suppl 6). 1141–1146. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bingshu E. Chen Breakdown of academic impact, for papers by Anastasia Ivanova Breakdown of academic impact, for papers by Craig A. Beam Breakdown of academic impact, for papers by Judy Zhong Breakdown of academic impact, for papers by Hwai‐I Yang Breakdown of academic impact, for papers by Nhu D. Le Breakdown of academic impact, for papers by Ivan Nestorov Breakdown of academic impact, for papers by Marvin A. Schneiderman Breakdown of academic impact, for papers by Tongzhang Zheng Breakdown of academic impact, for papers by Serge Koscielny
Rankless by CCL
2026